Compounding Solutions, the global leader in medical plastics compounding, is set to break ground on phase two of an expansion of their compounding facility located in Lewiston, Maine during the Spring of 2017. The new expansion will include office and warehouse space, as well as, two additional manufacturing areas, including a certified class 100,000 cleanroom for medical compounding.
This expansion will double the current footprint of the facility, bringing it to 120,000+ square feet of compounding, office, and warehouse space. The two new manufacturing areas will allow for the addition of 8 compounding lines.
“This expansion will provide us with the warehouse space we need today, plus the production capacity and facility resources that we will require over the next 5 years. Our current 13 compounding lines will grow to 21 through that period.” said Scott Neal, General Manager. “Furthermore, the addition of the cleanroom will allow us to produce the cleanest compounds possible and shows our continued investment in technology in an effort to provide the highest quality compounds to the medical device market.”
Phase one of the expansion was completed in the summer of 2016 with the addition of 4,000 sq. ft. of lab and record retention space. Phase two is the construction of the building expansion and phase three will be the addition of the class 100,000 certified cleanroom.
Compounding Solutions was started in 1999 with the purpose of becoming a leading compounder for the medical device industry. At the beginning, the company operated with two compounding lines and has experienced continued growth through the years. Currently, the company operates 13 compounding lines and has grown to over 70 employees.